| Mrs Mary E Caldwell, LCSWC | |
|
752 Trenton Ave, Severna Park, MD 21146-3908 | |
| (443) 897-2554 | |
| Not Available |
| Full Name | Mrs Mary E Caldwell |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 752 Trenton Ave, Severna Park, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336456789 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 08362 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Mary E Caldwell, LCSWC 752 Trenton Ave, Severna Park, MD 21146-3908 Ph: (443) 897-2554 | Mrs Mary E Caldwell, LCSWC 752 Trenton Ave, Severna Park, MD 21146-3908 Ph: (443) 897-2554 |
News Archive
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
The University of Illinois at Chicago has been awarded a $9.6 million, five-year grant from the National Institutes of Health to establish an Autism Center of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
When the heart is stopped and restarted, the patient's life may be saved but their brain is often permanently damaged. Therapeutic hypothermia, a treatment in which the patient's body temperature is lowered and maintained several degrees below normal for a period of time, has been shown to mitigate these harmful effects and improve survival in adults.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
› Verified 9 days ago
Mrs. Kristen Mary Deboy Caminiti, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 877 Baltimore Annapolis Blvd, Suite 300, Severna Park, MD 21146 Phone: 410-294-0152 | |
Sophie Sterling, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86 Kennedy Dr, Severna Park, MD 21146 Phone: 508-443-1162 | |
Katelyn Riegger, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 815 Ritchie Hwy Ste 205, Severna Park, MD 21146 Phone: 443-261-5376 | |
Mr. Michael Patrick Wall, LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 692 Ritchie Hwy, Suite 203, Severna Park, MD 21146 Phone: 410-647-4862 | |
Sharmila Rose Clee, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 517 Benfield Rd Ste 100, Severna Park, MD 21146 Phone: 410-216-4421 | |
Peter Grube, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 819 Richie Highway, Suite 2005, Severna Park, MD 21146 Phone: 410-647-6005 | |
Mrs. Karlene S Haines, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, Suite 107, Severna Park, MD 21146 Phone: 443-481-9028 |